<p>A fused pyrrole compound represented by the general formula (1): (1) (wherein the symbols have the same meanings as in the description), a prodrug thereof, or a pharmaceutically acceptable salt of either. The compound (1), prodrug, and salt are useful as a therapeutic agent for diabetes which has HLGPa inhibitory activity.</p>
申请公布号
WO2004113345(A1)
申请公布日期
2004.12.29
申请号
WO2004JP08917
申请日期
2004.06.18
申请人
JAPAN TOBACCO INC.;NAKAMURA, TAKESHI;TAKAGI, MASAKI;KIGUCHI, TOSHIHIRO;IKENOGAMI, TAKU;UEDA, NOBUHISA
